Back to Newsroom

Early Breast Cancer Detection: Why Timing Matters

Tanya Gupta, M.D.

Medical Director

Understanding how age, family history, and breast density influence your screening decisions

A woman looking ahead thoughtfully beside three icons linked by a curved line: a calendar with a check mark, an awareness ribbon, and a group of people.

When it comes to breast health, knowledge is one of the most valuable tools you have. Understanding your personal risk, staying current with recommended screening, and knowing when to ask about additional options can help you take a more active role in your care.

Breast cancer is one of the most common cancers affecting women in the United States. Yet advances in screening and treatment have helped improve outcomes, particularly when breast cancer is found before it spreads.

The key takeaway: Finding breast cancer at an earlier stage is generally associated with better outcomes and may expand treatment options. Regular screening and timely evaluation of concerning symptoms remain important parts of breast health.

Breast Cancer Risk Changes with Age

Breast cancer can develop at any adult age, but the likelihood of diagnosis generally increases as women get older.

According to the American Cancer Society's Cancer Facts & Figures 2025, breast cancer remains a major health concern for American women.1

Understanding how risk changes throughout adulthood helps explain why screening recommendations vary by age.

  • Women under 40: Breast cancer is less common, but it can occur, particularly among women with inherited genetic variants or significant family histories.

  • Women ages 40–49: Breast cancer risk increases, making routine screening an important consideration.

  • Women ages 50–64: Breast cancer becomes more common, and continued screening remains important.

  • Women ages 65 and older: Breast cancer risk remains substantial. Screening decisions should reflect age, overall health, and individual circumstances.

Age is important, but it is not the only factor. Family history, genetic risk, breast density, and previous breast findings can also influence a woman's screening needs.

Why Breast Cancer Stage at Diagnosis Matters

One of the clearest ways to understand the importance of early detection is to examine breast cancer survival by the extent of disease at diagnosis.

The National Cancer Institute reports the following five-year relative survival rates for women diagnosed with breast cancer, based on SEER data from 2016–2022.2

Extent of breast cancer at diagnosisFive-year relative survival
Localized — confined to the breast100.0%
Regional — spread to nearby lymph nodes or tissues87.5%
Distant — spread to other parts of the body33.8%

Five-year relative survival compares survival among people with breast cancer with survival among people in the general population of the same age and sex.

These figures demonstrate how strongly outcomes are associated with the extent of cancer at diagnosis.

They are population averages, not predictions for individual patients. Survival also depends on age, tumor biology, overall health, and response to treatment.

How Does Early Detection Improve Outcomes?

Finding breast cancer before it spreads can provide important advantages.

More treatment options. Earlier-stage cancers may be treated with less extensive surgery and may require fewer types of treatment, depending on the cancer's characteristics.

A greater opportunity for successful treatment. Breast cancer confined to the breast generally has a more favorable prognosis than cancer that has spread beyond the breast.

Evidence shows that recommended mammography screening reduces breast cancer mortality.

Why Breast Density Matters for Early Detection

Nearly half of women age 40 and older who undergo mammography have dense breasts.

Breast density refers to the proportion of fibrous and glandular tissue compared with fatty tissue in the breast.

Dense tissue and many breast cancers both appear white on a mammogram. This can make abnormalities more difficult to distinguish from surrounding tissue.

Breast density also independently increases breast cancer risk.

That means women with dense breasts face two important considerations:

  1. They may have a higher likelihood of developing breast cancer.

  2. Mammograms may be less sensitive in detecting certain cancers.

Being aware of your breast density is an important part of understanding your individual risk and screening options.

When Might Additional Breast Cancer Screening Beyond a Mammogram Be Considered?

Mammography remains the foundation of routine breast cancer screening and has been shown to reduce breast cancer mortality.

The U.S. Preventive Services Task Force (USPSTF) recommends mammography every two years for women ages 40–74 at average risk.3 Other guidelines may recommend different intervals based on age and individual risk, such as the National Comprehensive Cancer Network (NCCN) breast cancer screening guidelines that recommend annual mammograms for women.4

For some women, particularly those with elevated breast cancer risk, supplemental screening with breast MRI or ultrasound may be appropriate.

Newer approaches, including blood-based technologies, are also being studied and developed to provide additional information. Certitude® is a blood-based test designed to support care decisions for women with dense breasts. It is intended to complement conversations with healthcare providers, not replace mammography or recommended diagnostic imaging.

Take a Proactive Approach to Your Breast Health

Being proactive doesn't mean undergoing every available test. It means understanding your risk and making informed decisions with your healthcare provider.

At your next appointment, consider asking:

  • What is my personal risk of developing breast cancer?

  • Do I have dense breasts, and what is my density category?

  • What screening schedule is appropriate for my age and risk?

  • Would additional screening provide meaningful benefits for me?

  • What should I do if I notice a breast change between screenings?

The Right Information at the Right Time

Early breast cancer detection is about more than identifying disease. It's about giving women and their healthcare teams the opportunity to make informed decisions at the most appropriate time.

Knowing your breast density, understanding your individual risk, and following recommended screening can help you move forward with greater confidence.

Take the next step: Review your latest mammogram report, learn your breast density, and talk with your healthcare provider about the screening plan that's right for you.

Read more about how to read your mammogram report in What to Do After Receiving a Dense Breast Notification.

Footnotes

  1. Cancer Facts & Figures 2025 | American Cancer Society ↩

  2. Survival Rates and Prognosis for Breast Cancer - NCI ↩

  3. Recommendation: Breast Cancer: Screening | United States Preventive Services Taskforce ↩

  4. NCCN Guidelines for Patients: Breast Cancer Screening and Diagnosis ↩

Certitude

1000 Westgate Drive
St. Paul, MN 55114

© Astrin Biosciences 2025. All rights reserved.

The Certitude Test is a laboratory developed test (LDT) from Astrin Biosciences Inc., and is performed by Clinical Laboratory Improvement Amendments (CLIA) certified, College of American Pathologists (CAP) accredited laboratories qualified to conduct high-complexity clinical testing and is only intended for use consistent with applicable CLIA and CAP requirements. The Certitude test performance characteristics were validated by Astrin Biosciences following CAP and CLIA regulations. When offered as an LDT, the Certitude Test has not been cleared or approved by the U.S. Food and Drug Administration (FDA).